| Titre : | Addiction, Vol.107, Suppl.1 - November 2012 - Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study |
| Auteurs : | E. S. BANDSTRA, Éditeur scientifique |
| Type de document : | Bulletin : Périodique |
| Paru le : | 15/11/2012 |
| Année de publication : | 2012 |
| Format : | 1-97 |
| Langues: | Anglais |
| Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
| Mots-clés : |
Thésaurus TOXIBASE OPIOIDES ; HEROINE ; OPIACES ; MORPHINE ; MEDICAMENTS ; MERE ; TRAITEMENT ; NOUVEAU-NE ; BUPRENORPHINE ; METHADONE ; ETUDE RANDOMISEE ; GROSSESSE ; FOETUS ; SYNDROME DE SEVRAGE |
| Résumé : |
CONTENTS:
• Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses. Bandstra E.S., p. 1-4. • Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Jones H.E., Heil S.H., Baewert A., Arria A.M., Kaltenbach K., Martin P.R., et al., p. 5-27. • Maternal Opioid Treatment: Human Experimental Research (MOTHER) - approach, issues and lessons learned. Jones H.E., Fischer G., Heil S.H., Kaltenbach K., Martin P.R., Coyle M.G., et al., p. 28-35. • Fetal assessment before and after dosing with buprenorphine or methadone. Salisbury A.L., Coyle M.G., O'Grady K.E., Heil S.H., Martin P.R., Stine S.M., et al., p. 36-44. • Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Kaltenbach K., Holbrook A.M., Coyle M.G., Heil S.H., Salisbury A.L., Stine S.M., et al., p. 45-52. • Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Gaalema D.E., Scott T.L., Heil S.H., Coyle M.G., Kaltenbach K., Badger G.J., et al., p. 53-62. • Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Coyle M.G., Salisbury A.L., Lester B.M., Jones H.E., Lin H., Graf-Rohrmeister K., et al., p. 63-73. • Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Benningfield M.M., Dietrich M.S., Jones H.E., Kaltenbach K., Heil S.H., Stine S.M., et al., p. 74-82. • Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Holbrook A.M., Baxter J.K., Jones H.E., Heil S.H., Coyle M.G., Martin P.R., et al., p. 83-90. • Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. McNicholas L.F., Holbrook A.M., O'Grady K.E., Jones H.E., Coyle M.G., Martin P.R., et al., p. 91-97. |
| Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
| Cote : | Abonnement |
| Lien : | http://onlinelibrary.wiley.com/doi/10.1111/add.2012.107.issue-s1/issuetoc |
Dépouillements
Ajouter le résultat dans votre panier
Article : Périodique
H. E. JONES ;
S. H. HEIL ;
A. BAEWERT ;
A. M. ARRIA ;
K. KALTENBACH ;
P. R. MARTIN ;
M. G. COYLE ;
P. SELBY ;
G. FISCHER
|
Aims: This paper reviews the published literature regarding outcomes following maternal treatment with buprenorphine in five areas: maternal efficacy, fetal effects, neonatal effects, effects on breast milk and longer-term developmental effects.[...]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
